• Sep 15, 2026

  $29.95-5.01%

  Shares fell 5.01%, a larger decline than the average -1.67% move among comparable pharmaceutical preparations companies, where 3 of 5 fell and 2 rose [1]. The decline came on volume 1.6x the trailing average, with the session trading between 29.70 and 31.25 [2].

  • 1Peer group
  • 2Market data

• Sep 14, 2026

  $31.53-1.41%

• Sep 11, 2026

  $31.98-0.47%

  Shares slipped slightly, in line with comparable pharmaceutical preparations companies, which averaged a -0.92% move on the day [1].

  • 1Peer group

• Sep 10, 2026

  $32.13-1.74%

  Comparable pharmaceutical companies fell 3.41% on average, with all 5 tracked peers declining, while this stock fell 1.74% [1].

  • 1Peer group

• Sep 9, 2026

  $32.70-2.91%

  Comparable pharmaceutical preparations companies rose 0.76% on average [1], with three of five peers falling and two rising, while Viking Therapeutics fell 2.91%, a decline not shared by the broader cohort [1].

  • 1Peer group

• Sep 8, 2026

  $33.68-3.41%

  VKTX fell 3.41% alongside a broader decline in comparable pharmaceutical preparations companies, which moved -5.30% on average with all five falling [1].

  • 1Peer group

• Sep 4, 2026

  $34.87+2.62%

  VKTX shares rose 2.62% on a day when comparable pharmaceutical preparations companies were little changed, averaging -0.10% [1], indicating the move was not shared by its peer group [1].

  • 1Peer group

Closing prices for VKTX. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.